SOCIETY ON SARCOPENIA, CACHEXIA, & WASTING DISORDERS (SCWD)
The Leading International Conference on Cachexia, Sarcopenia & Muscle Wasting
Join clinicians, researchers and experts advancing the science of muscle wasting disorders. Over 400 clinicians and researchers from 45+ countries attend SCWD each year
- 📍 Washington, DC •
- December 10–12, 2026
From Basic Science to Clinical Management of Sarcopenia, Cachexia and Wasting
Multidisciplinary Approaches to Improve Patients’ Outcomes
The Society on Sarcopenia, Cachexia, and Wasting Disorders (SCWD) focuses on muscle wasting across a number of medical conditions and strives to enhance global health by advancing cutting-edge research that informs effective policies and practices for medical professionals and healthcare stakeholders.
Our mission is to address the challenges of cachexia (including cancer cachexia), sarcopenia, and wasting disorders involving all stakeholders to improve the lives of patients with cachexia and sarcopenia worldwide.
Explore the latest programs and information about Sarcopenia, Cachexia, & Wasting Disorders
Stay Involved
SCIENCE & RESEARCH
Your Area of Expertise
Explore our Programs and Resources
- 🗓️ Date: 2026-04-20
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2026-04-18
- 📰 Journal: Cancer Cell
- 🗓️ Date: 2026-04-17
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2026-04-17
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2026-04-17
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2026-04-17
- 📰 Journal: Clinical Nutrition
- 🗓️ Date: 2026-04-17
- 📰 Journal: Journals Of Gerontology Series A-Biological Sciences And Medical Sciences
- 🗓️ Date: 2026-04-16
- 📰 Journal: Aging Cell
Development of a spatially defined 3D in vitro coculture construct modelling pancreatic cancer-associated cachexia.
Exercise and Weekly Sirolimus (Rapamycin) in Older Adults: RAPA-EX-01 Randomised, Double-Blind, Placebo-Controlled Trial.
PBK-Loaded secretory autophagosomes drive radiotherapy-induced systemic adipose depletion via MAPK/ERK-PRKA/PKA-LIPE/HSL signaling: a therapeutic target for esophageal cancer cachexia.
Disuse-Induced Muscle Atrophy and Muscle Weakness From Hospitalization to Spaceflight: Exercise Succeeds in Prevention and Treatment-A Meta-Analysis.
Our Dedication to Advancing Science
The Journal of Cachexia, Sarcopenia and Muscle is committed to pioneering research that addresses the critical challenges of cachexia and sarcopenia. By publishing the finest work from across the life sciences, we unite experts to push the boundaries of knowledge and improve patient care. Discover how our journal can support your research through opportunities for publication and collaboration.
Register Now!
Embrace this opportunity to redefine the field and create lasting impact in the lives of patients worldwide.
